These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 21763239)

  • 21. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
    Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
    Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
    Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
    J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.
    Schirren CA; Jung MC; Gerlach JT; Worzfeld T; Baretton G; Mamin M; Hubert Gruener N; Houghton M; Pape GR
    Hepatology; 2000 Sep; 32(3):597-603. PubMed ID: 10960455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Núñez-Roldán A; Aguilar-Reina J
    J Viral Hepat; 2011 Oct; 18(10):e541-9. PubMed ID: 21914075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection.
    Chang KM; Thimme R; Melpolder JJ; Oldach D; Pemberton J; Moorhead-Loudis J; McHutchison JG; Alter HJ; Chisari FV
    Hepatology; 2001 Jan; 33(1):267-76. PubMed ID: 11124845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
    Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
    Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
    Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
    Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
    Mueller M; Spangenberg HC; Kersting N; Altay T; Blum HE; Klenerman P; Thimme R; Semmo N
    J Hepatol; 2010 Jun; 52(6):800-11. PubMed ID: 20416967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.
    Della Bella S; Crosignani A; Riva A; Presicce P; Benetti A; Longhi R; Podda M; Villa ML
    Immunology; 2007 Jun; 121(2):283-92. PubMed ID: 17462079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation.
    Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
    Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
    Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection.
    Semmo N; Day CL; Ward SM; Lucas M; Harcourt G; Loughry A; Klenerman P
    Hepatology; 2005 May; 41(5):1019-28. PubMed ID: 15841456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.
    Oliviero B; Varchetta S; Paudice E; Michelone G; Zaramella M; Mavilio D; De Filippi F; Bruno S; Mondelli MU
    Gastroenterology; 2009 Sep; 137(3):1151-60, 1160.e1-7. PubMed ID: 19470388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance.
    Ruys TA; Nanlohy NM; van den Berg CH; Hassink E; Beld M; van de Laar T; Bruisten S; Wit F; Krol A; Prins M; Lange J; van Baarle D
    J Viral Hepat; 2008 Jun; 15(6):409-20. PubMed ID: 18221302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.